Literature DB >> 16247658

Role of VEGF-C and VEGF-D in lymphangiogenesis in gastric cancer.

Yutaka Yonemura1, Yoshio Endo, Kayoko Tabata, Taiichi Kawamura, Hyo-Yung Yun, Etsurou Bandou, Takuma Sasaki, Masahiro Miura.   

Abstract

BACKGROUND: The molecular mechanisms of lymphangiogenesis induced by vascular endothelial growth factor (VEGF)-C and VEGF-D in gastric cancer were studied.
METHODS: VEGF-C and VEGF-D gene expression vectors were transfected into the gastric cancer cell line KKLS, which did not originally express VEGF-C and VEGF-D, and stable transfectants (KKLS/VEGF-C and KKLS/VEGF-D) were established. The cell lines were inoculated into the subserosal layer of the stomach and subcutaneous tissue of nude mice.
RESULTS: VEGF-C and VEGF-D expression in KKLS/VEGF-C and KKLS/VEGF-D cells was found by reverse transcription polymerase chain reaction (RT-PCR) and Western blot analysis. Expression of mouse VEGF receptor (VEGFR)-2 and mouse VEGFR-3 mRNA was detected in the KKLS/VEGF-C and KKLS/VEGF-D gastric tumors. Newly formed lymphatic vessels were detected not only in the periphery but also in the center of the tumors. The intratumor lymphatic vessels connected with the preexisting lymphatic vessels in the muscularis mucosa. The average numbers of lymphatic vessels in KKLS/VEGF-C (52.0 +/- 9.5) and KKLS/VEGF-D (16.4 +/- 0.6) gastric tumors were significantly higher than that in the KKLS/control vector tumors (4.0 +/- 1.4).
CONCLUSION: VEGF-C and VEGF-D may induce neoformation of lymphatic vessels in experimental gastric tumors by the induction of VEGFR-3 expression.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16247658     DOI: 10.1007/s10147-005-0508-7

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.402


  34 in total

1.  The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.

Authors:  Vickie Hanrahan; Margaret J Currie; Sarah P Gunningham; Helen R Morrin; Prudence A E Scott; Bridget A Robinson; Stephen B Fox
Journal:  J Pathol       Date:  2003-06       Impact factor: 7.996

2.  Molecular cloning of a novel vascular endothelial growth factor, VEGF-D.

Authors:  Y Yamada; J Nezu; M Shimane; Y Hirata
Journal:  Genomics       Date:  1997-06-15       Impact factor: 5.736

3.  Expression of vascular endothelial growth factors A, B, C, and D and their relationships to lymph node status in lung adenocarcinoma.

Authors:  T Niki; S Iba; M Tokunou; T Yamada; Y Matsuno; S Hirohashi
Journal:  Clin Cancer Res       Date:  2000-06       Impact factor: 12.531

4.  Biosynthesis of vascular endothelial growth factor-D involves proteolytic processing which generates non-covalent homodimers.

Authors:  S A Stacker; K Stenvers; C Caesar; A Vitali; T Domagala; E Nice; S Roufail; R J Simpson; R Moritz; T Karpanen; K Alitalo; M G Achen
Journal:  J Biol Chem       Date:  1999-11-05       Impact factor: 5.157

5.  Multiple protein 4.1 isoforms produced by alternative splicing in human erythroid cells.

Authors:  J G Conboy; J Chan; N Mohandas; Y W Kan
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

6.  Expression of vascular endothelial growth factor family members in head and neck squamous cell carcinoma correlates with lymph node metastasis.

Authors:  P O-charoenrat; P Rhys-Evans; S A Eccles
Journal:  Cancer       Date:  2001-08-01       Impact factor: 6.860

7.  Absence of functional lymphatics within a murine sarcoma: a molecular and functional evaluation.

Authors:  A J Leu; D A Berk; A Lymboussaki; K Alitalo; R K Jain
Journal:  Cancer Res       Date:  2000-08-15       Impact factor: 12.701

8.  Relationship between expression of plasminogen activator system and metastatic ability in human cancers.

Authors:  M Noguchitakino; Y Endo; Y Yonemura; T Sasaki
Journal:  Int J Oncol       Date:  1996-01       Impact factor: 5.650

9.  Lymphatic metastasis in the absence of functional intratumor lymphatics.

Authors:  Timothy P Padera; Ananth Kadambi; Emmanuelle di Tomaso; Carla Mouta Carreira; Edward B Brown; Yves Boucher; Noah C Choi; Douglas Mathisen; John Wain; Eugene J Mark; Lance L Munn; Rakesh K Jain
Journal:  Science       Date:  2002-04-25       Impact factor: 47.728

10.  Expression of vascular endothelial growth factor A, B, C, and D in oral squamous cell carcinoma.

Authors:  Satoru Shintani; Chunnan Li; Tohru Ishikawa; Mariko Mihara; Koh-ichi Nakashiro; Hiroyuki Hamakawa
Journal:  Oral Oncol       Date:  2004-01       Impact factor: 5.337

View more
  30 in total

1.  Identification of microRNAs associated with lymphangiogenesis in human gastric cancer.

Authors:  B Yang; C Jing; J Wang; X Guo; Y Chen; R Xu; L Peng; J Liu; L Li
Journal:  Clin Transl Oncol       Date:  2013-07-24       Impact factor: 3.405

Review 2.  The roles of vascular endothelial growth factor in bone repair and regeneration.

Authors:  Kai Hu; Bjorn R Olsen
Journal:  Bone       Date:  2016-06-25       Impact factor: 4.398

3.  STAT3 regulation the expression of VEGF-D in HGC-27 gastric cancer cell.

Authors:  Jingyu Deng; Jingli Cui; Nan Jiang; Rupeng Zhang; Li Zhang; Xishan Hao; Han Liang
Journal:  Am J Transl Res       Date:  2014-11-22       Impact factor: 4.060

Review 4.  Intraperitoneal free cancer cells in gastric cancer: pathology of peritoneal carcinomatosis and rationale for intraperitoneal chemotherapy/hyperthermic intraperitoneal chemotherapy in gastric cancer.

Authors:  Zhong-He Ji; Kai-Wen Peng; Yan Li
Journal:  Transl Gastroenterol Hepatol       Date:  2016-09-19

5.  Vascular endothelial growth factor receptors 1,3 and caveolin-1 are implicated in colorectal cancer aggressiveness and prognosis--correlations with epidermal growth factor receptor, CD44v6, focal adhesion kinase, and c-Met.

Authors:  Alexandros Garouniatis; Adamantia Zizi-Sermpetzoglou; Spyros Rizos; Alkiviadis Kostakis; Nikolaos Nikiteas; Athanasios G Papavassiliou
Journal:  Tumour Biol       Date:  2013-04-12

6.  Different significance between intratumoral and peritumoral lymphatic vessel density in gastric cancer: a retrospective study of 123 cases.

Authors:  Xiao-Lei Wang; Jian-Ping Fang; Ru-Yong Tang; Xi-Mei Chen
Journal:  BMC Cancer       Date:  2010-06-17       Impact factor: 4.430

7.  K-ras mutation status correlates with the expression of VEGFR1, VEGFR2, and PDGFRalpha in colorectal cancer.

Authors:  Carl C Schimanski; Tim Zimmermann; Irene Schmidtmann; Ines Gockel; Hauke Lang; Peter R Galle; Markus Moehler; Martin R Berger
Journal:  Int J Colorectal Dis       Date:  2009-11-20       Impact factor: 2.571

8.  Last line therapy with sorafenib in colorectal cancer: A retrospective analysis.

Authors:  Ksenia Martchenko; Irene Schmidtmann; Thomas Thomaidis; Verena Thole; Peter R Galle; Marc Becker; Markus Möhler; Thomas C Wehler; Carl C Schimanski
Journal:  World J Gastroenterol       Date:  2016-06-21       Impact factor: 5.742

9.  Coexpression of receptor-tyrosine-kinases in gastric adenocarcinoma--a rationale for a molecular targeting strategy?

Authors:  Daniel Drescher; Markus Moehler; Ines Gockel; Kirsten Frerichs; Annett Müller; Friedrich Dünschede; Thomas Borschitz; Stefan Biesterfeld; Martin Holtmann; Thomas Wehler; Andreas Teufel; Kerstin Herzer; Thomas Fischer; Martin R Berger; Theodor Junginger; Peter R Galle; Carl C Schimanski
Journal:  World J Gastroenterol       Date:  2007-07-14       Impact factor: 5.742

10.  Lymphangiogenesis induced by VEGF-C and VEGF-D promotes metastasis and a poor outcome in breast carcinoma: a retrospective study of 61 cases.

Authors:  Yan Gu; Xiaoliang Qi; Shanyu Guo
Journal:  Clin Exp Metastasis       Date:  2008-05-30       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.